Management of candidemia and invasive candidiasis

被引：5

作者：

Taieb, F. ^{[1
,2
]}

Mechai, F. ^{[1
,2
]}

Lefort, A. ^{[3
]}

Lanternier, F. ^{[1
,2
]}

Bougnoux, M. -E. ^{[6
]}

Lortholary, O. ^{[1
,2
,4
,5
]}

机构：

[1] Ctr Infectiol Necker Pasteur, Paris, France

[2] Univ Paris 05, Hop Necker Enfants Malad, Serv Malad Infect & Trop, Ctr Infectiol Necker Pasteur, F-75743 Paris 15, France

[3] Univ Paris Diderot, Hop Beaujon, Serv Med Interne, F-92110 Clichy, France

[4] Ctr Natl Reference Mycol & Antifong, Inst Pasteur, F-75015 Paris, France

[5] CNRS, URA 3012, Paris, France

[6] Univ Paris 05, Hop Necker Enfants Malad, Serv Mycol & Parasitol, F-75015 Paris, France

来源：

REVUE DE MEDECINE INTERNE | 2011年 / 32卷 / 03期

关键词：

Candida spp; Invasive infection; Treatment; BLOOD-STREAM INFECTIONS; INTENSIVE-CARE-UNIT; HOSPITAL-ACQUIRED CANDIDEMIA; IN-VITRO SUSCEPTIBILITIES; LIPOSOMAL AMPHOTERICIN-B; RISK-FACTORS; FUNGAL-INFECTIONS; RANDOMIZED-TRIAL; CANCER-PATIENTS; EPIDEMIOLOGY;

D O I：

10.1016/j.revmed.2010.08.019

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Candida species is the fourth most common cause of bloodstream infection and is the leading cause of invasive fungal infection among hospitalized patients. Acute disseminated candidiasis remains a life-threatening disease that now occurs mainly in intensive care units hospitalized patients. Delay in treatment of Candida bloodstream infections could be minimized by the development of more rapid and sensitive diagnostic techniques for the identification of Candida bloodstream infections. Current guidelines for the management of invasive candidiasis recommend fluconazole or an echinocandin as the primary therapeutic option. The optimal choice of the antifungal agent should depend on local epidemiology, prior antifungal therapy and patient's characteristics. (c) 2010 Societe nationale francaise de medecine interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.

引用

页码：173 / 180

页数：8

共 53 条

[31] A prospective observational study of candidemia: Epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients [J].

Pappas, PG ;

Rex, JH ;

Lee, J ;

Hamill, RJ ;

Larsen, RA ;

Powderly, W ;

Kauffman, CA ;

Hyslop, N ;

Mangino, JE ;

Chapman, S ;

Horowitz, HW ;

Edwards, JE ;

Dismukes, WE .

CLINICAL INFECTIOUS DISEASES, 2003, 37 (05) :634-643

[32] International surveillance of bloodstream infections due to Candida species:: Frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program [J].

Pfaller, MA ;

Diekema, DJ ;

Jones, RN ;

Sader, HS ;

Fluit, AC ;

Hollis, RJ ;

Messer, SA .

JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (09) :3254-3259

[33] Multicenter randomized trial of fluconazole versus amphotericin B for treatment of candidemia in non-neutropenic patients [J].

Phillips, P ;

Shafran, S ;

Garber, G ;

Rotstein, C ;

Smaill, F ;

Fong, I ;

Salit, I ;

Miller, M ;

Williams, K ;

Conly, JM ;

Singer, J ;

Ioannou, S .

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1997, 16 (05) :337-345

[34] Anidulafungin versus fluconazole for invasive candidiasis [J].

Reboli, Annette C. ;

Rotstein, Coleman ;

Pappas, Peter G. ;

Chapman, Stanley W. ;

Kett, Daniel H. ;

Kumar, Deepali ;

Betts, Robert ;

Wible, Michele ;

Goldstein, Beth P. ;

Schranz, Jennifer ;

Krause, David S. ;

Walsh, Thomas J. ;

Van Wijngaerden, E. ;

Bow, E. ;

Garber, G. ;

Laverdiere, M. ;

Libman, M. ;

Pelletier, R. ;

Sanche, S. ;

Cornely, O. ;

Kern, W. ;

Ruhnke, M. ;

Carosi, G. ;

Verweij, P. ;

Anaissie, E. ;

Bochan, M. ;

Carpenter, C. ;

Cicogna, C. ;

Cleary, J. ;

Finley, N. ;

Fetchick, R. ;

Friedman, B. ;

Graham, D. ;

Graybill, R. ;

Hsiao, C. ;

Jones, R. ;

Kerkering, T. ;

Kurtz, T. ;

McClain, D. ;

Nowakowski, J. ;

Ostrosky-Zeichner, L. ;

Perfect, J. ;

Pullman, J. ;

Quartin, A. ;

Reinhardt, J. ;

Segal, B. ;

Shahryar, S. ;

Shoham, S. ;

Sioson, P. ;

Sloan, L. .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (24) :2472-2482

[35] INTRAVASCULAR CATHETER EXCHANGE AND DURATION OF CANDIDEMIA [J].

REX, JH ;

BENNETT, JE ;

SUGAR, AM ;

PAPPAS, PG ;

SERODY, J ;

EDWARDS, JE ;

WASHBURN, RG .

CLINICAL INFECTIOUS DISEASES, 1995, 21 (04) :994-996

[36] A RANDOMIZED TRIAL COMPARING FLUCONAZOLE WITH AMPHOTERICIN-B FOR THE TREATMENT OF CANDIDEMIA IN PATIENTS WITHOUT NEUTROPENIA [J].

REX, JH ;

BENNETT, JE ;

SUGAR, AM ;

PAPPAS, PG ;

VANDERHORST, CM ;

EDWARDS, JE ;

WASHBURN, RG ;

SCHELD, WM ;

KARCHMER, AW ;

DINE, AP ;

LEVENSTEIN, MJ ;

WEBB, CD .

NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (20) :1325-1330

[37]

RIBADEAUDUMAS F, 2008, MED SCI, V24, P24

[38] Candidemia in French hospitals: incidence rates and characteristics [J].

Richet, H ;

Roux, P ;

Des Champs, C ;

Esnault, Y ;

Andremont, A .

CLINICAL MICROBIOLOGY AND INFECTION, 2002, 8 (07) :405-412

[39] Impact of early central venous catheter removal on outcome in patients with candidaemia [J].

Rodriguez, D. ;

Park, B. J. ;

Almirante, B. ;

Cuenca-Estrella, M. ;

Planes, A. M. ;

Mensa, J. ;

Gimenez, M. ;

Saballs, P. ;

Fridkin, S. K. ;

Rodriguez-Tudela, J. L. ;

Pahissa, A. .

CLINICAL MICROBIOLOGY AND INFECTION, 2007, 13 (08) :788-793

[40] Epidemiology of candidaemia in Europe: Results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study [J].

Tortorano, AM ;

Peman, J ;

Bernhardt, H ;

Klingspor, L ;

Kibbler, CC ;

Faure, O ;

Biraghi, E ;

Canton, E ;

Zimmermann, K ;

Seaton, S ;

Grillot, R .

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2004, 23 (04) :317-322

← 1 2 3 4 5 6 →